Research Library

The authors explore a causal relationship between the 2017 tax reform and a decline in wealth inequality.

The unproven stem cell intervention industry is a worldwide, direct-to-consumer market where clinics offer stem cells or stem cell-derived components to patients with little to no scientific or clinical basis. In this paper, the authors call for the establishment of a World Health Organization Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. Stem Cell Reports: https://doi.org/10.1016/j.stemcr.2021.05.004

It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.

To understand the variations and impact of national policies, the authors reviewed and analyzed IVF, hESC and human embryo research laws or national guidelines currently in place in the top R&D-investing nations. Regenerative Medicine, Aug. 17, 2020.

This study highlights areas where efforts could be made to address policy issues, institutional barriers and national biases to promote more productive collaboration in the global scientific community.

Gene editing in humans raises ethical and safety issues that require further discussion to identify a responsible way forward.

The authors examine the role that government policy can play in accelerating production and use of biochar at commercial scale, such as providing commercial financial incentives, nonfinancial policy support and research and development funding. The article also includes broad recommendations for the development of policy that maximizes the net benefits of biochar adoption.

The connection between Texas H.B. 810, which allows clinics to provide investigational stem cell treatments to certain patients, and a deregulation movement to increase patient access to unproven stem cell treatments is described in this report.

By Kirstin R.W. Matthews and Melody T. Tan Vaccines and vaccine exemptions are increasingly contentious issues in Texas. In this issue brief, the authors dispel five common misconceptions about vaccines that were presented during public hearings at the Texas House of Representatives in 2017.

In this brief, the authors analyze transcripts from public hearrings at the Texas legislature to identify key arguments against school-mandated vaccinations. To ensure public health, policymakers and other stakeholders should be well informed about vaccines, the impact of vaccine-preventable disease, and the risks associated with putting absolute individual rights above public health concerns, they conclude.